{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T05:32:47Z","timestamp":1649136767575},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T00:00:00Z","timestamp":1562025600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T00:00:00Z","timestamp":1562025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s12640-019-00082-2","type":"journal-article","created":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T08:03:22Z","timestamp":1562054602000},"page":"645-652","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Usefulness of the Serum Cystatin C Levels in Patients with Transient Ischemic Attack"],"prefix":"10.1007","volume":"36","author":[{"given":"Xiaoyu","family":"Dong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianfei","family":"Nao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,2]]},"reference":[{"key":"82_CR1","doi-asserted-by":"publisher","first-page":"279","DOI":"10.18071\/isz.71.0279","volume":"71","author":"T Acar","year":"2018","unstructured":"Acar T, Guzey Aras Y, Gul SS, Acar BA (2018) Can high uric acid levels be an independent risk factor for acute ischemic stroke due to large-artery atherosclerosis? Ideggyogyaszati Szemle-Clin Neurosci 71:279\u2013283. \n                    https:\/\/doi.org\/10.18071\/isz.71.0279","journal-title":"Ideggyogyaszati Szemle-Clin Neurosci"},{"key":"82_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000451061","volume":"43","author":"P Appelros","year":"2017","unstructured":"Appelros P, Berglund MH, Strom JO (2017) Long-term risk of stroke after transient ischemic attack. Cerebrovasc Dis 43:25\u201330. \n                    https:\/\/doi.org\/10.1159\/000451061","journal-title":"Cerebrovasc Dis"},{"issue":"1","key":"82_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1177\/1708538118797551","volume":"27","author":"Jos\u00e9 Carlos Ar\u00e9valo-Lorido","year":"2018","unstructured":"Arevalo-Lorido JC, Carretero-Gomez J, Robles Perez-Monteoliva NR (2018) Association between serum uric acid and carotid disease in patients with atherosclerotic acute ischemic stroke. Vascular 1708538118797551-1708538118797551. \n                    https:\/\/doi.org\/10.1177\/1708538118797551","journal-title":"Vascular"},{"key":"82_CR4","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1161\/strokeaha.109.570010","volume":"41","author":"A Chandratheva","year":"2010","unstructured":"Chandratheva A, Geraghty OC, Luengo-Fernandez R, Rothwell PM, Oxford Vasc S (2010) ABCD(2) score predicts severity rather than risk of early recurrent events after transient ischemic attack. Stroke 41:851\u2013856. \n                    https:\/\/doi.org\/10.1161\/strokeaha.109.570010","journal-title":"Stroke"},{"key":"82_CR5","doi-asserted-by":"publisher","unstructured":"Chen W, Pan Y, Jing J, Zhao X, Liu L, Meng X, Wang Y, Wang Y, the CHANCE Investigators, the CHANCE Investigators, Johnston SC, Wang Z, Xia H, Li B, Zhang G, Ren X, Ji C, Zhang G, Li J, Lu B, Wang L, Feng S, Wang D, Tang W, Li J, Zhang H, Li G, Wang B, Chen Y, Lian Y, Liu B, Teng J, Sui R, Li L, Yuan Z, Zang D, Lu Z, Sun L, Wang D, Hou L, Yuan D, Cao Y, Li H, Tan X, Wang H, du H, Liu M, Wang S, Liu Q, Zhang Z, Cui Q, Wang R, Zhao J, Zhang J, Zhao J, Bi Q, Qi X, Liu J, Li C, Li L, Pan X, Zhang J, Jiao D, Han Z, Qian D, Xiao J, Xing Y, du H, Huang G, Cui Y, Li Y, Feng L, Gao L, Xiao B, Cao Y, Wu Y, Liu J, Zhang Z, Dong Z, Wang L, He L, Wang X, Guo X, Wang M, Wang X, Jiang J, Zhao R, Zhou S, Hu H, He M, Yu F, Ouyang Q, Zhang J, Xu A, Qi X, Wang L, Shi F, Guo F, Wang J, Zhao F, Dou R, Wei D, Meng Q, Xia Y, Wang S, Xue Z, Xu Y, Ma L, Wang C, Wu J, Du Y, Wang Y, Xiao L, Song F, Hu W, Chen Z, Liu Q, Zhang J, Chen M, Yuan X, Liu Z, Li G, Li X, Tian T (2017) Recurrent stroke in minor ischemic stroke or transient ischemic attack with metabolic syndrome and\/or diabetes mellitus. J Am Heart Assoc 6. \n                    https:\/\/doi.org\/10.1161\/jaha.116.005446","DOI":"10.1161\/jaha.116.005446"},{"key":"82_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1177\/1479164117738156","volume":"15","author":"YK Chung","year":"2018","unstructured":"Chung YK, Lee YJ, Kim KW, Cho RK, Chung SM, Moon JS, Yoon JS, Won KC, Lee HW (2018) Serum cystatin C is associated with subclinical atherosclerosis in patients with type 2 diabetes: a retrospective study. Diab Vasc Dis Res 15:24\u201330. \n                    https:\/\/doi.org\/10.1177\/1479164117738156","journal-title":"Diab Vasc Dis Res"},{"key":"82_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1053\/ajkd.2000.8237","volume":"36","author":"E Coll","year":"2000","unstructured":"Coll E, Botey A, Alvarez L, Poch E, Quint\u00f3 L, Saurina A, Vera M, Piera C, Darnell A (2000) Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis 36:29\u201334. \n                    https:\/\/doi.org\/10.1053\/ajkd.2000.8237","journal-title":"Am J Kidney Dis"},{"key":"82_CR8","doi-asserted-by":"publisher","first-page":"4057","DOI":"10.1016\/j.molimm.2008.06.028","volume":"45","author":"AE Davis 3rd","year":"2008","unstructured":"Davis AE 3rd, Mejia P, Lu F (2008) Biological activities of C1 inhibitor. Mol Immunol 45:4057\u20134063. \n                    https:\/\/doi.org\/10.1016\/j.molimm.2008.06.028","journal-title":"Mol Immunol"},{"key":"82_CR9","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1161\/01.str.21.6.848","volume":"21","author":"M Dennis","year":"1990","unstructured":"Dennis M, Bamford J, Sandercock P, Warlow C (1990) Prognosis of transient ischemic attacks in the Oxfordshire Community Stroke Project. Stroke 21:848\u2013853. \n                    https:\/\/doi.org\/10.1161\/01.str.21.6.848","journal-title":"Stroke"},{"key":"82_CR10","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s10143-012-0432-z","volume":"36","author":"NR Gonzalez","year":"2013","unstructured":"Gonzalez NR, Liebeskind DS, Dusick JR, Mayor F, Saver J (2013) Intracranial arterial stenoses: current viewpoints, novel approaches, and surgical perspectives. Neurosurg Rev 36:175\u2013184; discussion 184\u2013175. \n                    https:\/\/doi.org\/10.1007\/s10143-012-0432-z","journal-title":"Neurosurg Rev"},{"key":"82_CR11","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1080\/01616412.2016.1187825","volume":"38","author":"G-x Huang","year":"2016","unstructured":"Huang G-x, Ji X-m, Ding Y-c, Huang H-y (2016) Association between serum cystatin C levels and the severity or potential risk factors of acute ischemic stroke. Neurol Res 38:518\u2013523. \n                    https:\/\/doi.org\/10.1080\/01616412.2016.1187825","journal-title":"Neurol Res"},{"key":"82_CR12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0006-8993(95)01232-X","volume":"709","author":"H Ishimaru","year":"1996","unstructured":"Ishimaru H, Ishikawa K, Ohe Y, Takahashi A, Maruyama Y (1996) Cystatin C and apolipoprotein E immunoreactivities in CA1 neurons in ischemic gerbil hippocampus. Brain Res 709:155\u2013162","journal-title":"Brain Res"},{"key":"82_CR13","doi-asserted-by":"publisher","first-page":"2901","DOI":"10.1001\/jama.284.22.2901","volume":"284","author":"SC Johnston","year":"2000","unstructured":"Johnston SC, Gress DR, Browner WS, Sidney S (2000) Short-term prognosis after emergency department diagnosis of TIA. Jama-J Am Med Assoc 284:2901\u20132906. \n                    https:\/\/doi.org\/10.1001\/jama.284.22.2901","journal-title":"Jama-J Am Med Assoc"},{"key":"82_CR14","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.diabers.2018.02.003","volume":"139","author":"R Kaneko","year":"2018","unstructured":"Kaneko R, Sawada S, Tokita A, Honkura R, Tamura N, Kodama S, Izumi T, Takahashi K, Uno K, Imai J, Yamada T, Miyachi Y, Hasegawa H, Kanai H, Ishigaki Y, Katagiri H (2018) Serum cystatin C level is associated with carotid arterial wall elasticity in subjects with type 2 diabetes mellitus: a potential marker of early-stage atherosclerosis. Diabetes Res Clin Pract 139:43\u201351. \n                    https:\/\/doi.org\/10.1016\/j.diabers.2018.02.003","journal-title":"Diabetes Res Clin Pract"},{"key":"82_CR15","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.1016\/j.ijcard.2013.01.231","volume":"168","author":"DA Kanhai","year":"2013","unstructured":"Kanhai DA, Visseren FLJ, van der Graaf Y, Schoneveld AH, Catanzariti LM, Timmers L, Kappelle LJ, Uiterwaal CSPM, Lim SK, Sze SK, Pasterkamp G, de Kleijn DPV (2013) Microvesicle protein levels are associated with increased risk for future vascular events and mortality in patients with clinically manifest vascular disease. Int J Cardiol 168:2358\u20132363. \n                    https:\/\/doi.org\/10.1016\/j.ijcard.2013.01.231","journal-title":"Int J Cardiol"},{"key":"82_CR16","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1111\/j.1523-1755.2004.00517.x","volume":"65","author":"EL Knight","year":"2004","unstructured":"Knight EL, Verhave JC, Spiegelman D, Hillege HL, De Zeeuw D, Curhan GC, De Jong PE (2004) Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 65:1416\u20131421. \n                    https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00517.x","journal-title":"Kidney Int"},{"key":"82_CR17","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1159\/000075786","volume":"17","author":"WWM Lam","year":"2004","unstructured":"Lam WWM, Wong KS, So NMC, Yeung TK, Gao S (2004) Plaque volume measurement by magnetic resonance imaging as an index of remodeling of middle cerebral artery: correlation with transcranial color Doppler and magnetic resonance angiography. Cerebrovasc Dis 17:166\u2013169. \n                    https:\/\/doi.org\/10.1159\/000075786","journal-title":"Cerebrovasc Dis"},{"key":"82_CR18","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12883-018-1203-4","volume":"18","author":"S Lu","year":"2018","unstructured":"Lu S, Xie J, Su C, Ge S, Shi H, Hong X (2018) Plasma homocysteine levels and intracranial plaque characteristics: association and clinical relevance in ischemic stroke. BMC Neurol 18:200. \n                    https:\/\/doi.org\/10.1186\/s12883-018-1203-4","journal-title":"BMC Neurol"},{"key":"82_CR19","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/s1474-4422(10)70240-4","volume":"9","author":"A Merwick","year":"2010","unstructured":"Merwick A, Albers GW, Amarenco P, Arsava EM, Ay H, Calvet D, Coutts SB, Cucchiara BL, Demchuk AM, Furie KL, Giles MF, Labreuche J, Lavall\u00e9e PC, Mas JL, Olivot JM, Purroy F, Rothwell PM, Saver JL, Sheehan \u00d3C, Stack JP, Walsh C, Kelly PJ (2010) Addition of brain and carotid imaging to the ABCD(2) score to identify patients at early risk of stroke after transient ischaemic attack: a multicentre observational study. Lancet Neurol 9:1060\u20131069. \n                    https:\/\/doi.org\/10.1016\/s1474-4422(10)70240-4","journal-title":"Lancet Neurol"},{"key":"82_CR20","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1161\/strokeaha.107.489625","volume":"38","author":"L Ni","year":"2007","unstructured":"Ni L, L\u00fc J, Bo Hou L, Tao Yan J, Fan Q, Hui R, Cianflone K, Wang W, Wen Wang D (2007) Cystatin C, associated with hemorrhagic and ischemic stroke, is a strong predictor of the risk of cardiovascular events and death in Chinese. Stroke 38:3287\u20133288. \n                    https:\/\/doi.org\/10.1161\/strokeaha.107.489625","journal-title":"Stroke"},{"key":"82_CR21","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ejvs.2008.10.015","volume":"37","author":"CP Oates","year":"2009","unstructured":"Oates CP, Naylor AR, Hartshorne T, Charles SM, Fail T, Humphries K, Aslam M, Khodabakhsh P (2009) Joint recommendations for reporting carotid ultrasound investigations in the United Kingdom. Eur J Vasc Endovasc Surg 37:251\u2013261. \n                    https:\/\/doi.org\/10.1016\/j.ejvs.2008.10.015","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"82_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-14-127","volume":"14","author":"MY Oh","year":"2014","unstructured":"Oh MY, Lee H, Kim JS, Ryu WS, Lee SH, Ko SB, Kim C, Kim CH, Yoon BW (2014) Cystatin C, a novel indicator of renal function, reflects severity of cerebral microbleeds. BMC Neurol 14:127. \n                    https:\/\/doi.org\/10.1186\/1471-2377-14-127","journal-title":"BMC Neurol"},{"key":"82_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0006-8993(95)00520-Z","volume":"691","author":"DE Palm","year":"1995","unstructured":"Palm DE, Knuckey NW, Primiano MJ, Spangenberger AG, Johanson CE (1995) Cystatin C, a protease inhibitor, in degenerating rat hippocampal neurons following transient forebrain ischemia. Brain Res 691:1\u20138","journal-title":"Brain Res"},{"key":"82_CR24","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.neulet.2005.10.091","volume":"395","author":"TJ Pirttila","year":"2006","unstructured":"Pirttila TJ, Pitkanen A (2006) Cystatin C expression is increased in the hippocampus following photothrombotic stroke in rat. Neurosci Lett 395:108\u2013113. \n                    https:\/\/doi.org\/10.1016\/j.neulet.2005.10.091","journal-title":"Neurosci Lett"},{"key":"82_CR25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1136\/svn-2017-000073","volume":"2","author":"M Saedon","year":"2017","unstructured":"Saedon M, Hutchinson CE, Imray CHE, Singer DRJ (2017) ABCD2 risk score does not predict the presence of cerebral microemboli in patients with hyper-acute symptomatic critical carotid artery stenosis. Stroke Vasc Neurol 2:41\u201346. \n                    https:\/\/doi.org\/10.1136\/svn-2017-000073","journal-title":"Stroke Vasc Neurol"},{"key":"82_CR26","first-page":"230","volume":"34","author":"B Tejera-Segura","year":"2016","unstructured":"Tejera-Segura B, de Vera-Gonzalez AM, Lopez-Mejias R, Gonzalez-Gay MA, Ferraz-Amaro I (2016) Serum cathepsin S and cystatin C: relationship to subclinical carotid atherosclerosis in rheumatoid arthritis. Clin Exp Rheumatol 34:230\u2013235","journal-title":"Clin Exp Rheumatol"},{"key":"82_CR27","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1017\/s0007114509991048","volume":"102","author":"KAR Tobin","year":"2009","unstructured":"Tobin KAR, Holven KB, Retterstol K, Strom E, Ose L, Aukrust P, Nenseter MS (2009) Cystatin C levels in plasma and peripheral blood mononuclear cells among hyperhomocysteinaemic subjects: effect of treatment with B-vitamins. Br J Nutr 102:1783\u20131789. \n                    https:\/\/doi.org\/10.1017\/s0007114509991048","journal-title":"Br J Nutr"},{"key":"82_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000443338","volume":"6","author":"T Umemura","year":"2016","unstructured":"Umemura T, Kawamura T, Mashita S, Kameyama T, Sobue G (2016) Higher levels of cystatin C are associated with extracranial carotid artery steno-occlusive disease in patients with noncardioembolic ischemic stroke. Cerebrovasc Dis Extra 6:1\u201311. \n                    https:\/\/doi.org\/10.1159\/000443338","journal-title":"Cerebrovasc Dis Extra"},{"key":"82_CR29","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1161\/strokeaha.117.016726","volume":"48","author":"DT Winovich","year":"2017","unstructured":"Winovich DT et al (2017) Factors associated with ischemic stroke survival and recovery in older adults. Stroke 48:1818\u2212+. \n                    https:\/\/doi.org\/10.1161\/strokeaha.117.016726","journal-title":"Stroke"},{"key":"82_CR30","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1007\/s00415-012-6453-2","volume":"259","author":"D Xiao","year":"2012","unstructured":"Xiao D, Liu H, Zhang H, Luo Y (2012) Impact of cystatin C levels on infarct size and hemorrhage volume in acute cerebral stroke. J Neurol 259:2053\u20132059. \n                    https:\/\/doi.org\/10.1007\/s00415-012-6453-2","journal-title":"J Neurol"},{"key":"82_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12640-015-9522-3","volume":"28","author":"B Yang","year":"2015","unstructured":"Yang B, Zhu J, Miao Z, Zhou B, Ge W, Zhao H, Xu X (2015) Cystatin C is an independent risk factor and therapeutic target for acute ischemic stroke. Neurotox Res 28:1\u20137. \n                    https:\/\/doi.org\/10.1007\/s12640-015-9522-3","journal-title":"Neurotox Res"},{"key":"82_CR32","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.09.007","volume":"26","author":"S Yang","year":"2017","unstructured":"Yang S, Cai J, Lu R, Wu J, Zhang M, Zhou X (2017a) Association between serum cystatin C level and total magnetic resonance imaging burden of cerebral small vessel disease in patients with acute lacunar stroke. J Stroke Cerebrovasc Dis 26:186\u2013191. \n                    https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2016.09.007","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"82_CR33","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.09.007","volume":"26","author":"S Yang","year":"2017","unstructured":"Yang S, Cai J, Lu R, Wu J, Zhang M, Zhou X (2017b) Association between serum cystatin C level and total magnetic resonance imaging burden of cerebral small vessel disease in patients with acute lacunar stroke. J Stroke Cerebrovasc Dis 26:186\u2013191. \n                    https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2016.09.007","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"82_CR34","doi-asserted-by":"publisher","first-page":"40","DOI":"10.2174\/1567202612666150102150941","volume":"12","author":"Q Zeng","year":"2015","unstructured":"Zeng Q, Lin K, Yao M, Wei L (2015) Significant correlation between cystatin C, cerebral infarction, and potential biomarker for increased risk of stroke. Curr Neurovasc Res 12:40\u201346. \n                    https:\/\/doi.org\/10.2174\/1567202612666150102150941","journal-title":"Curr Neurovasc Res"},{"key":"82_CR35","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.atherosclerosis.2018.05.015","volume":"274","author":"Z Zhu","year":"2018","unstructured":"Zhu Z, Zhong C, Xu T, Wang A, Peng Y, Xu T, Peng H, Chen CS, Wang J, Li Q, Geng D, Sun Y, Li Y, Zhang Y, He J (2018a) Prognostic significance of serum cystatin C in acute ischemic stroke patients according to lipid component levels. Atherosclerosis 274:146\u2013151. \n                    https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.05.015","journal-title":"Atherosclerosis"},{"key":"82_CR36","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.atherosclerosis.2018.05.015","volume":"274","author":"Z Zhu","year":"2018","unstructured":"Zhu Z, Zhong C, Xu T, Wang A, Peng Y, Xu T, Peng H, Chen CS, Wang J, Li Q, Geng D, Sun Y, Li Y, Zhang Y, He J (2018b) Prognostic significance of serum cystatin C in acute ischemic stroke patients according to lipid component levels. Atherosclerosis 274:146\u2013151. \n                    https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.05.015","journal-title":"Atherosclerosis"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-019-00082-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-019-00082-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-019-00082-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:22:53Z","timestamp":1593562973000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-019-00082-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,2]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["82"],"URL":"https:\/\/doi.org\/10.1007\/s12640-019-00082-2","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,2]]},"assertion":[{"value":"11 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. Formal consent is not required for this type of study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Conduct"}}]}}